• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格列本脲作为一种强效血管升压药,用于治疗猪体外循环和再灌注后血管麻痹。

Glibenclamide Serves as a Potent Vasopressor to Treat Vasoplegia After Cardiopulmonary Bypass and Reperfusion in a Porcine Model.

作者信息

Winter Andreas, Nepper Pascal, Hermann Marcus, Bayer Franziska, Riess Stephanie, Salem Razan, Hlavicka Jan, Prinzing Anatol, Hecker Florian, Holubec Tomas, Zacharowski Kai, Walther Thomas, Emrich Fabian

机构信息

Department of Cardiovascular Surgery, University Hospital Frankfurt, Goethe University, 60629 Frankfurt am Main, Germany.

Central Research Unit, Goethe University Frankfurt, 60629 Frankfurt am Main, Germany.

出版信息

Int J Mol Sci. 2025 Apr 24;26(9):4040. doi: 10.3390/ijms26094040.

DOI:10.3390/ijms26094040
PMID:40362279
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12071602/
Abstract

The hemodynamic stabilization of patients after complex cardiac surgery is a daily challenge. The use of high doses of catecholamines is common but has potential adverse effects. Glibenclamide, a K blocker, seems to attenuate vasoplegia in different animal models of septic shock. Therefore, the aim of this study was to investigate the impact of Glibenclamide on the vasoplegic syndrome after cardiopulmonary bypass in a porcine model. In this experimental study, 20 landrace pigs were randomized into two groups and examined: In the control group, standard medical therapy, including norepinephrine, was used, and in the study group standard medical therapy plus additional Glibenclamide was administered. Following general anesthesia, prolonged cardiopulmonary bypass and aortic cross-clamping was performed. In the study group, Glibenclamide was administered 45 min after weaning from cardiopulmonary bypass. The dosage used was 10 mg/kg as a bolus, followed by a continuous infusion of 10 mg/kg/h. Hemodynamic and laboratory measurements were performed. Glibenclamide had a relevant effect on circulatory parameters. With increasing vascular resistance and blood pressure, norepinephrine was able to be reduced. While the heart rate dropped to physiological levels, the cardiac index decreased as well. The results lead to the conclusion that Glibenclamide was able to break through vasoplegic syndrome and could therefore serve as a potent drug to stabilize patients after cardiac surgery.

摘要

复杂心脏手术后患者的血流动力学稳定是一项日常挑战。高剂量使用儿茶酚胺很常见,但有潜在的不良反应。格列本脲是一种钾通道阻滞剂,在不同的脓毒性休克动物模型中似乎能减轻血管麻痹。因此,本研究的目的是在猪模型中研究格列本脲对体外循环后血管麻痹综合征的影响。在这项实验研究中,将20头长白猪随机分为两组并进行检查:对照组采用包括去甲肾上腺素在内的标准药物治疗,研究组采用标准药物治疗加额外的格列本脲。全身麻醉后,进行长时间的体外循环和主动脉交叉阻断。在研究组中,体外循环撤机后45分钟给予格列本脲。使用的剂量为10mg/kg静脉推注,随后以10mg/kg/h持续输注。进行了血流动力学和实验室测量。格列本脲对循环参数有显著影响。随着血管阻力和血压升高,去甲肾上腺素用量能够减少。虽然心率降至生理水平,但心脏指数也下降了。结果得出结论,格列本脲能够突破血管麻痹综合征,因此可作为一种有效药物用于稳定心脏手术后的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad6/12071602/00e4fa184d1e/ijms-26-04040-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad6/12071602/1ce11cd2e806/ijms-26-04040-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad6/12071602/2b88c91e8e36/ijms-26-04040-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad6/12071602/7d68f133c524/ijms-26-04040-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad6/12071602/fbdf9a966c5f/ijms-26-04040-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad6/12071602/250de3d49f51/ijms-26-04040-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad6/12071602/1a2a99c26d8b/ijms-26-04040-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad6/12071602/00e4fa184d1e/ijms-26-04040-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad6/12071602/1ce11cd2e806/ijms-26-04040-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad6/12071602/2b88c91e8e36/ijms-26-04040-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad6/12071602/7d68f133c524/ijms-26-04040-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad6/12071602/fbdf9a966c5f/ijms-26-04040-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad6/12071602/250de3d49f51/ijms-26-04040-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad6/12071602/1a2a99c26d8b/ijms-26-04040-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad6/12071602/00e4fa184d1e/ijms-26-04040-g007.jpg

相似文献

1
Glibenclamide Serves as a Potent Vasopressor to Treat Vasoplegia After Cardiopulmonary Bypass and Reperfusion in a Porcine Model.格列本脲作为一种强效血管升压药,用于治疗猪体外循环和再灌注后血管麻痹。
Int J Mol Sci. 2025 Apr 24;26(9):4040. doi: 10.3390/ijms26094040.
2
Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study.血管扩张性休克治疗(ATHOS-3)研究的事后分析:血管扩张性心脏病手术后患者应用血管紧张素 II 治疗与血压快速反应和血管加压素节省相关。
J Cardiothorac Vasc Anesth. 2021 Jan;35(1):51-58. doi: 10.1053/j.jvca.2020.08.001. Epub 2020 Aug 7.
3
Use of Hydroxycobolamin in the Prevention of Vasoplegic Syndrome in Adult Patients Undergoing Cardiopulmonary Bypass: A Controlled Prospective Trial.羟基钴胺素在预防接受体外循环的成年患者血管麻痹综合征中的应用:一项对照前瞻性试验。
J Cardiothorac Vasc Anesth. 2025 May;39(5):1180-1187. doi: 10.1053/j.jvca.2025.02.001. Epub 2025 Feb 5.
4
[Vasoplegic syndrome and its treatment with vasopressin during cardiac surgery with cardiopulmonary bypass].[体外循环心脏手术期间的血管麻痹综合征及其血管加压素治疗]
Rev Med Chil. 2011 Mar;139(3):368-72. Epub 2011 Aug 25.
5
Vitamin C for Vasoplegia After Cardiopulmonary Bypass: A Case Series.体外循环后血管麻痹用维生素C:病例系列
A A Pract. 2018 Aug 15;11(4):96-99. doi: 10.1213/XAA.0000000000000752.
6
Factors associated with vasoplegic shock in the postoperative period of cardiac surgery and influence on morbidity and mortality of the use of arginine vasopressin as rescue therapy.心脏手术后并发血管扩张性休克的相关因素及精氨酸加压素作为抢救治疗的应用对发病率和死亡率的影响。
Med Intensiva (Engl Ed). 2024 Jul;48(7):392-402. doi: 10.1016/j.medine.2024.04.003. Epub 2024 May 1.
7
Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.用于体外循环后血管麻痹性休克的合成人血管紧张素II
J Cardiothorac Vasc Anesth. 2019 Nov;33(11):3080-3084. doi: 10.1053/j.jvca.2019.03.004. Epub 2019 Mar 8.
8
A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery.特利加压素静脉推注用于治疗心脏手术后难治性血管麻痹性低血压的回顾性分析。
Interact Cardiovasc Thorac Surg. 2009 Oct;9(4):588-92. doi: 10.1510/icvts.2009.209890. Epub 2009 Jul 6.
9
Use of Hydroxocobalamin (Vitamin B12a) in Patients With Vasopressor Refractory Hypotension After Cardiopulmonary Bypass: A Case Series.羟钴胺素(维生素 B12a)在体外循环后血管加压药抵抗性低血压患者中的应用:病例系列。
Anesth Analg. 2019 Jul;129(1):e1-e4. doi: 10.1213/ANE.0000000000003648.
10
Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.心血管手术后血管麻痹综合征:病理生理学和以结果为导向的治疗管理综述。
J Card Surg. 2021 Oct;36(10):3749-3760. doi: 10.1111/jocs.15805. Epub 2021 Jul 12.

本文引用的文献

1
Vasoplegic Syndrome in Cardiac Surgery: A Narrative Review of Etiologic Mechanisms and Therapeutic Options.心脏手术中的血管麻痹综合征:病因机制与治疗选择的叙述性综述
J Cardiothorac Vasc Anesth. 2025 Jul;39(7):1815-1829. doi: 10.1053/j.jvca.2025.02.047. Epub 2025 Mar 6.
2
Vasoplegic Syndrome Following Bypass: A Comprehensive Review of Pathophysiology and Proposed Treatments.体外循环后血管麻痹综合征:病理生理学及治疗建议的综合综述
Cureus. 2025 Jan 27;17(1):e78057. doi: 10.7759/cureus.78057. eCollection 2025 Jan.
3
Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial.
静脉注射格列本脲治疗大面积半球性脑卒后脑水肿(CHARM):一项 3 期、双盲、安慰剂对照、随机试验。
Lancet Neurol. 2024 Dec;23(12):1205-1213. doi: 10.1016/S1474-4422(24)00425-3.
4
Glibenclamide Alleviates LPS-Induced Acute Lung Injury through NLRP3 Inflammasome Signaling Pathway.格列本脲通过 NLRP3 炎性小体信号通路减轻 LPS 诱导的急性肺损伤。
Mediators Inflamm. 2022 Feb 11;2022:8457010. doi: 10.1155/2022/8457010. eCollection 2022.
5
Vasoplegia Following Orthotopic Heart Transplantation: Prevalence, Predictors and Clinical Outcomes.原位心脏移植术后血管麻痹:发生率、预测因素和临床结局。
J Card Fail. 2022 Apr;28(4):617-626. doi: 10.1016/j.cardfail.2021.11.020. Epub 2021 Dec 30.
6
Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.心血管手术后血管麻痹综合征:病理生理学和以结果为导向的治疗管理综述。
J Card Surg. 2021 Oct;36(10):3749-3760. doi: 10.1111/jocs.15805. Epub 2021 Jul 12.
7
Role of Sulfonylurea Receptor 1 and Glibenclamide in Traumatic Brain Injury: A Review of the Evidence.磺酰脲受体 1 和格列本脲在创伤性脑损伤中的作用:证据综述。
Int J Mol Sci. 2020 Jan 9;21(2):409. doi: 10.3390/ijms21020409.
8
Effect of IV glyburide on adjudicated edema endpoints in the GAMES-RP Trial.在 GAMES-RP 试验中,静脉注射格列吡嗪对已判决的水肿终点的影响。
Neurology. 2018 Dec 4;91(23):e2163-e2169. doi: 10.1212/WNL.0000000000006618. Epub 2018 Nov 16.
9
Definitions and pathophysiology of vasoplegic shock.血管扩张性休克的定义和病理生理学。
Crit Care. 2018 Jul 6;22(1):174. doi: 10.1186/s13054-018-2102-1.
10
Glibenclamide Mimics Metabolic Effects of Metformin in H9c2 Cells.格列本脲模拟二甲双胍对H9c2细胞的代谢作用。
Cell Physiol Biochem. 2017;43(3):879-890. doi: 10.1159/000481638. Epub 2017 Sep 28.